China Reform Health Management and Services Group Co., Ltd. (SHE:000503)
China · Delayed Price · Currency is CNY 6.40
+0.10 (1.59%)
Jul 10, 2026, 3:04 PM CST
SHE:000503 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 350.33 | 350.28 | 356.73 | 329.95 | 310.89 | 252.33 |
Other Revenue | 0.17 | 0.17 | 0.17 | 0.17 | 0.19 | 0.19 |
| 350.5 | 350.44 | 356.9 | 330.13 | 311.08 | 252.52 | |
Revenue Growth (YoY) | -2.49% | -1.81% | 8.11% | 6.12% | 23.19% | 21.77% |
Cost of Revenue | 276.79 | 276.11 | 302.45 | 248.14 | 246.62 | 218.69 |
Gross Profit | 73.71 | 74.33 | 54.45 | 81.99 | 64.46 | 33.83 |
Selling, General & Admin | 211.88 | 211.83 | 190.37 | 190.4 | 163.74 | 149.04 |
Research & Development | 2.69 | 2.8 | 0.34 | 0.97 | 9.65 | 16.31 |
Other Operating Expenses | 1.98 | 1.53 | 1.79 | 1.11 | 1.96 | 1.76 |
Operating Expenses | 234.77 | 232.15 | 216.68 | 200.52 | 174.41 | 180.6 |
Operating Income | -161.06 | -157.82 | -162.23 | -118.53 | -109.95 | -146.77 |
Interest Expense | -11.64 | -10.87 | -8.31 | -5.12 | -1.98 | -2.49 |
Interest & Investment Income | 23.99 | 26.01 | 149.54 | 13.12 | 1.58 | 4.25 |
Earnings From Equity Investments | - | - | - | - | 4.02 | - |
Currency Exchange Gain (Loss) | -0.15 | -0.15 | 0.12 | -0.06 | -0.35 | -1.73 |
Other Non Operating Income (Expenses) | 1.2 | 1.2 | -1.27 | -0.71 | 7.09 | -0.76 |
EBT Excluding Unusual Items | -147.66 | -141.63 | -22.14 | -111.3 | -99.59 | -147.51 |
Gain (Loss) on Sale of Investments | -260.92 | -260.92 | 6.34 | 27.27 | 14.42 | -29.47 |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | 0.03 | 0.11 | 0.01 | 0.04 |
Asset Writedown | 1.06 | -1.31 | -0 | -2.71 | -0.37 | -0.05 |
Other Unusual Items | -0.04 | -0.01 | 4.08 | 8.22 | 2.34 | 0.06 |
Pretax Income | -407.6 | -403.92 | -11.69 | -78.41 | -83.19 | -176.92 |
Income Tax Expense | -0.55 | 0.07 | -0.23 | 1.91 | 1.13 | 0.2 |
Earnings From Continuing Operations | -407.05 | -403.99 | -11.47 | -80.32 | -84.32 | -177.12 |
Net Income to Company | -407.05 | -403.99 | -11.47 | -80.32 | -84.32 | -177.12 |
Minority Interest in Earnings | - | - | 1.09 | 0.53 | -0.01 | 1.3 |
Net Income | -407.05 | -403.99 | -10.38 | -79.79 | -84.33 | -175.82 |
Net Income to Common | -407.05 | -403.99 | -10.38 | -79.79 | -84.33 | -175.82 |
Shares Outstanding (Basic) | 979 | 979 | 979 | 911 | 907 | 901 |
Shares Outstanding (Diluted) | 979 | 979 | 979 | 911 | 907 | 901 |
Shares Change (YoY) | -0.01% | 0.03% | 7.46% | 0.46% | 0.67% | 0.21% |
EPS (Basic) | -0.42 | -0.41 | -0.01 | -0.09 | -0.09 | -0.20 |
EPS (Diluted) | -0.42 | -0.41 | -0.01 | -0.09 | -0.09 | -0.20 |
Free Cash Flow | -126.04 | -127.32 | -120.11 | -154.28 | -197.87 | -127.95 |
Free Cash Flow Per Share | -0.13 | -0.13 | -0.12 | -0.17 | -0.22 | -0.14 |
Gross Margin | 21.03% | 21.21% | 15.26% | 24.83% | 20.72% | 13.40% |
Operating Margin | -45.95% | -45.03% | -45.45% | -35.91% | -35.34% | -58.13% |
Profit Margin | -116.14% | -115.28% | -2.91% | -24.17% | -27.11% | -69.63% |
Free Cash Flow Margin | -35.96% | -36.33% | -33.65% | -46.73% | -63.61% | -50.67% |
EBITDA | -136.77 | -132.67 | -133.66 | -89.35 | -82.22 | -143.23 |
EBITDA Margin | -39.02% | -37.86% | -37.45% | -27.07% | -26.43% | -56.72% |
D&A For EBITDA | 24.29 | 25.14 | 28.57 | 29.18 | 27.73 | 3.54 |
EBIT | -161.06 | -157.82 | -162.23 | -118.53 | -109.95 | -146.77 |
EBIT Margin | -45.95% | -45.03% | -45.45% | -35.91% | -35.34% | -58.13% |
Revenue as Reported | 350.5 | 350.44 | 356.9 | 330.13 | 311.08 | 252.52 |
Advertising Expenses | - | 0.58 | 0.72 | 0.36 | 0.15 | 0.56 |